A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet Formulation

Clinical trial NCT06312787 · COMPLETED

Trial details

NCT number: NCT06312787
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2024-04-02
Primary completion: 2024-05-04
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.